Benzinga | Aug 11, 2020 04:25PM EDT

10x Genomics Q2 Net Loss $40.2M vs Loss $10.9M, Sales $42.90M Beat $29.56M Estimate

10x Genomics (NASDAQ:TXG) reported quarterly sales of $42.90 million which beat the analyst consensus estimate of $29.56 million by 45.13 percent. This is a 23.12 percent decrease over sales of $55.80 million the same period last year.